{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:18:21Z","timestamp":1717373901769},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.7759\/cureus.61536","type":"journal-article","created":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T17:45:55Z","timestamp":1717350355000},"source":"Crossref","is-referenced-by-count":0,"title":["Acquired Thrombotic Thrombocytopenic Purpura (TTP) Presenting With Synthetic Cannabinoid Use"],"prefix":"10.7759","author":[{"given":"Megan B","family":"Douglass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Yessin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Elengickal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon","family":"Charpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cayla","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I","volume":"79","year":"2014","unstructured":"Schedules of controlled substances. temporary placement of four synthetic cannabinoids into Schedule I. Fed Reg. 2014, 79:7577-82.","journal-title":"Fed Reg"},{"key":"ref2","unstructured":"CDC. About synthetic cannabinoids. (2021). Accessed: February 21, 2024: https:\/\/archive.cdc.gov\/www_cdc_gov\/nceh\/hsb\/envepi\/outbreaks\/sc\/About.html."},{"key":"ref3","article-title":"Synthetic cannabinoids: acute Intoxication","author":"Wang GS","year":"2023","unstructured":"Wang GS. Synthetic cannabinoids: acute Intoxication. UpToDate. Post, TW (ed): UpToDate, Waltham, MA; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6527a2","article-title":"Acute poisonings from synthetic cannabinoids - 50 U.S. toxicology investigators consortium registry sites, 2010-2015","volume":"65","author":"Riederer AM","year":"2016","unstructured":"Riederer AM, Campleman SL, Carlson RG, Boyer EW, Manini AF, Wax PM, Brent JA. Acute poisonings from synthetic cannabinoids - 50 U.S. toxicology investigators consortium registry sites, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016, 65:692-5. 10.15585\/mmwr.mm6527a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2017.05.05","article-title":"Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists","volume":"4","author":"Karass M","year":"2017","unstructured":"Karass M, Chugh S, Andries G, Mamorska-Dyga A, Nelson JC, Chander PN. Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists. Stem Cell Investig. 2017, 4:43. 10.21037\/sci.2017.05.05","journal-title":"Stem Cell Investig"},{"key":"ref6","article-title":"Diagnosis of immune TTP","author":"George JN","year":"2023","unstructured":"George JN, Cuker A. Diagnosis of immune TTP. UpToDate. Post TW (ed): UpToDate, Waltham. MA; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese JA","year":"2013","unstructured":"Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013, 60:1676-82. 10.1002\/pbc.24612","journal-title":"Pediatr Blood Cancer"},{"key":"ref8","article-title":"Immune TTP: initial treatment","author":"George JN","year":"2023","unstructured":"George JN, Cuker A. Immune TTP: initial treatment. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2023."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2014.898263","article-title":"Synthetic marijuana \"K2\" induced ITP","volume":"26","author":"\u00d6zt\u00fcrk E","year":"2015","unstructured":"\u00d6zt\u00fcrk E, Oral A, \u00d6zdemir M, Bambul N. Synthetic marijuana \"K2\" induced ITP. Platelets. 2015, 26:258-9. 10.3109\/09537104.2014.898263","journal-title":"Platelets"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235170-acquired-thrombotic-thrombocytopenic-purpura-ttp-presenting-with-synthetic-cannabinoid-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T17:45:58Z","timestamp":1717350358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235170-acquired-thrombotic-thrombocytopenic-purpura-ttp-presenting-with-synthetic-cannabinoid-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,2]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.61536","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,2]]}}}